ICTS unit will help pharma’s message reach doctors

By Phil Taylor

- Last updated on GMT

Related tags: Medicine

US contract research organisation Integrated Clinical Trial Services has set up a team that will help pharmaceutical companies communicate information on their products to the medical community.

The announcement is particularly timely, given the issuance of new guidelines by the US pharmaceutical trade body – Pharmaceutical Research and Manufacturers of America (PhRMA) - to issue new guidelines on how companies should interact with healthcare professionals.

Among the strictures in the new guidelines, which came into effect on January 1, is a ban on distributing office supplies, clothes and other gifts with company logos or product brand names to physicians and clinics. However, critics have taken issue with the absence of controls on the amount companies can pay doctors for consultancy services and to speak on behalf of their products.

ICTS’ new medical science liaison (MSL) service will be led by the company’s chief medical officer and vice president of clinical operations Dr. David Shearer.

It promises to “better communicate key information regarding new products and medical therapies to the medical community​,” according to an ICTS statement.

The MSL process can strengthen a product or therapy's market penetration by properly relaying vital information that educates key opinion leaders on a product or therapy and will create opportunities for product implementation​,” said the firm.

ICTS’ primary business is in the area of patient recruitment, enrolment and retention in clinical trials, via a network of 300 contract employees around the world.

Related news

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us


View more